BRAIN Biotech AG Logo

BRAIN Biotech AG

BNN | F

Overview

Corporate Details

ISIN(s):
DE0005203947 (+1 more)
LEI:
391200JKPVHLD6JLZ107
Country:
Germany
Address:
Darmstädter Straße 34-36, 64673 Zwingenberg
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

BRAIN Biotech AG is a German industrial biotechnology company that specializes in the development and production of innovative bio-based products and technologies. Founded in 1993, the company is headquartered in Zwingenberg, Germany, and has several subsidiaries and partnerships all over the world. BRAIN Biotech AG is a leader in the field of white biotechnology and focuses on using natural resources like microorganisms, enzymes, and bioactive compounds to develop sustainable solutions for industries ranging from agriculture to health. The company's technologies are used in applications as diverse as cosmetics, nutrition, pharmaceuticals, and chemicals. BRAIN Biotech AG's products and technologies are tailored to meet the specific requirements of its customers, ranging from large multinational corporations to small and medium-sized enterprises.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-23 08:30
Board/Management Information
Experienced biotechnology expert joins the Supervisory Board of BRAIN Biotech AG
English 13.4 KB
2025-06-23 08:05
Share Issue/Capital Change
Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billio…
English 22.4 KB
2025-05-28 07:30
Earnings Release
BRAIN Biotech AG reports final half-year figures for fiscal year 2024/25
English 20.0 KB
2025-05-28 00:00
Interim Report
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2024 bis zum 31.03…
German 99.2 KB
2025-05-28 00:00
Interim Report
Half-yearly financial report 2024/2025
English 364.5 KB
2025-05-21 10:00
M&A Activity
BRAIN Biotech announces buy-out of minorities, new continental European product…
English 16.2 KB
2025-05-19 11:23
Report Publication Announcement
English 4.1 KB
2025-05-19 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
German 5.8 KB
2025-05-19 00:00
Report Publication Announcement
Hinweis auf Halbjahresfinanzbericht vom 01.10.2024 bis zum 31.03.2025
German 5.8 KB
2025-04-30 17:54
Earnings Release
BRAIN Biotech AG reports preliminary Q2 figures and forecasts a more conservati…
English 6.0 KB
2025-03-19 16:45
Post-Annual General Meeting Information
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
English 14.6 KB
2025-03-18 16:45
Post-Annual General Meeting Information
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BR…
English 14.6 KB
2025-03-04 11:25
Director's Dealing
BRAIN Biotech AG: Michael Schneiders, buy
English 6.0 KB
2025-03-03 11:25
Director's Dealing
BRAIN Biotech AG: Michael Schneiders, buy
English 6.0 KB
2025-02-27 07:30
Earnings Release
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growt…
English 20.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-03 Schneiders, Michael Board Buy None 25,000.00 EUR
2025-01-16 Moelker, Adriaan Board Buy None 35,795.96 EUR

Peer Companies